Mr Mohsen El Gammal

FRCS Ed FEBS Breast Surgery

Mr El Gammal is a fully trained and UK accredited Oncoplastic, Reconstructive and Cosmetic Breast Surgeon. Over 25 years of experience with numerous research and international publications dedicated to breast surgery. Following his career in the NHS.

Mr Mohsen El Gammal Breast Surgeon profile photo at Cosmetic Surgery Partners London

Mr Mohsen El Gammal

Consultant Oncoplastic , Reconstructive & Cosmetic Surgeon 

Mr Mohsen El Gammal is a keen believer in patient centred care and works together with his patients and his team to provide the best care within strict evidenced based practises. He has published numerous peer-reviewed publications in highly respected international medical journals and conducted world-wide presentations in his field of expertise.

Mr El Gammal has over 25 years of experience solely dedicated to breast surgery and breast reconstructive surgery. He undertook his specialist training in the UK and Spain. He is on the GMC Specialist Register for Breast surgery, European Board Certified in Breast Surgery (FEBS) and The Associations of Breast Surgery (ABS)(BASO)(ESSO). 

Mr El Gammal has also done additional further training, undertaking courses in Advanced Breast Reconstruction and Cosmetic Breast Surgery at the European School of Microvascular Breast Surgery and the Paris Oncoplastic Masterclass at the European School of Surgery.  He has developed special interest in surgery for correction of developmental breast abnormalities such as tuberous breast, asymmetrical breasts and Macromastia. Happy to offer second opinion,  breast revision surgery and breast transgender surgery.

In addition to Mr El Gammal’s career and academic achievements, which includes being a leading name in sentinel lymph node and radioguided breast surgery (ROLL) in the UK and Europe, he has top academic and clinical research experience. He was an associate professor of surgery at the University of Kalamoon, Syria, has had his research published in numerous peer-reviewed journals and is a noted speaker in his field of expertise.

Procedures

Qualifications

  • European Board of Surgery (EBQS) Qualification / Breast Surgery.
  • PG Diploma in Breast Reconstructive Microsurgery Universitat Autònoma de Barcelona UAB.
  • PG Diploma in Cancer Studies, Plymouth University.
  • FRCS Edinburgh
  • MB BCh (with Honors) Cairo University, Egypt
  • Memberships
  • Fellow European Board of Surgery FEBS
  • Breast Surgery Association of Breast Surgery (ABS) 
  • British Association of Cancer Surgery (BASO) European Society of Surgical Oncology (ESSO) Royal College of Surgeons of Edinburgh 
  • British Medical Association (BMA) 
  • GMC specialist Register 
  • Medical and Dental Defense Union of Scotland  

Publication in peer reviewed journals

  • Original Research Articles in a Peer Reviewed Journals 
  • The feasibility of prehabilitation as part of the breast cancer treatment pathway
  • F. Wu  R. Laza-Cagigas  A. Pagarkar  A. Olaoke  M. El Gammal  T. Rampal
  • 25 December 2020  https://doi.org/10.1002/pmrj.12543
  • Improved immediate breast reconstruction as a result of oncoplastic multidisciplinary meeting. El Gammal MM, Lim M, Uppal R, Sainsbury R. Breast Cancer: Targets and Therapy. 2017; 9:293. 
  • Accuracy of ultrasound scan guided needle biopsy in Pre-Operative diagnosis of metastatic axillary lymphadenopathy in patients with breast cancer. M EL Gammal, C Ng, A Kumar, M Moorland, R Gardy, R Sainsbury. Breast Cancer Reports. 2017; 4:1. 
  • http://dx.doi.org/10.7243/2057-1631-4-1 
  • Time to go wireless? A 15-year single institution experience of radioisotope occult lesion Localisation (ROLL) for impalpable breast lesions. Hawkins SC, Brown I, King P, El- Gammal M, Stepp K, Widdison S, Barta M, Jackson N, Drew P, English R, Ahmad S. Eur J Surg Oncol. 2017 Jan; 43(1):62-67 
  • Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial. Douek M, Klaase J, Monypenny I, [EL- GAMMEL M] · R E Mansel. SentiMAG Trialists Group. Ann Surg Oncol. 2014 Apr; 21(4):1237-45. 
Contact Us
About Us